The global Pharma 4.0 market is witnessing rapid transformation as the pharmaceutical industry embraces digitalization and advanced manufacturing technologies. Valued at US$ 10.9 billion in 2022, the market is projected to expand at a remarkable CAGR of 17.7% from 2023 to 2031, surpassing US$ 46.9 billion by the end of 2031. This growth is fueled by increasing demand for personalized medicine,...